期刊文献+

奥曲肽对人胃癌细胞株抑制作用机制的实验研究 被引量:2

Mechanism of inhibition of human gastric cancer cell line growth in vitro by the somatostatin analog octreotide
下载PDF
导出
摘要 目的 研究奥曲肽 (OCT)对人胃癌细胞株MKN45生长的调控机制。方法 采用流式细胞术分析OCT1 0 -3 g L对MKN45细胞的周期分布的影响。结果  1 0 -3 g L这一浓度可诱导MKN45出现G0 G1 阻滞 ,于加入OCT后 6h开始 [(63 .67± 3 .92 ) % ] ,2 4h最显著 [(75 .0 5± 3 .42 ) % ] (P <0 .0 5) ,36h已消失 ;与对照组 [(7.0 3±0 .54) % ]相比 ,2 4hG2 M期细胞比例亦减少 [(2 .41± 1 .97) % ] ,但OCT未改变亚二倍体细胞的比例。结论 OCT可抑制人胃癌细胞株MKN45的生长 ,其作用机制之一是诱导细胞出现G0 G1 Objective To study the effect and mechanism the somatostatin analog octreotide exerts on the growth of human gastric cancer cell MKN45. Methods MTT colorimetric assay and flow cytometric analysis of DNA histograms were used to measure the proliferation and cell cycle distribution of MKN45 cell. Results 10 -2 ,10 -3 ,and 10 -4 g/L OCT exerted inhibitory actions on MKN45 cells, and the maximum inhibitory rate was 10.4% at 10 -3 g/L OCT. OCT(10 -3 g/L) also induced MKN45 to G 0/G 1 arrest, which began[(63.67±3.92)%]6 h after OCT was added, reached the maximum at 24 h (75.05%± 3.42%), and then disappeared at 36 h. At 24 h, the percentage of G 2/M cells also decreased [(2.41±1.97)%], compared with the control[(7.03±0.54)%]. OCT did not change the percentage of hypodiploid cells. Conclusion Inhibition of the growth of human gastric cancer cell MKN45 in vitro by the somatostatin analog octreotide involves G 0/G 1 phase arrest.
作者 王少卿 王绪
出处 《徐州医学院学报》 CAS 2002年第4期310-312,共3页 Acta Academiae Medicinae Xuzhou
关键词 奥曲肽 胃癌 实验研究 生长抑素 MKN45细胞株 G0/G1阻滞 流式细胞术 somatostatin cell cycle arrest gastric neoplasm
  • 相关文献

参考文献1

二级参考文献5

共引文献18

同被引文献16

  • 1陈劲松,梁庆模.生长抑素对胃肠癌的治疗[J].中国药房,2007,18(8):632-634. 被引量:4
  • 2Susini C,Buscail L.Rationale for the use of somatostatin analogs as antitumor agents[J].Ann Oncol,2006,17(12):1733-1742.
  • 3Guillermet-Guibert J,Lahlou H,Cordelier P,et al.Physiology of somatostatin receptors[J].J Endocrinol Invest,2005,28(11 Suppl):5-9.
  • 4Tejeda M,Gaal D,Hullan L,et al.Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models[J].Anticancer Res,2006,26(5A):3477-3483.
  • 5Erlandsen SE,Fykse V,Waldum HL,et al.Octreotide induces apoptosis in the oxyntic mucosa[J].Mol Cell Endocrinol,2007,264(1-2):188-196.
  • 6Patel YC.Somatostatin and its receptor family[J].Front Neuroendocrinol,1999,20(3):157-198.
  • 7Berruti A,Dogliotti L,Mosca A,et al.Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A,prostate-specific antigen,and insulin-like growth factor-1 in advancedprostate cancer patients[J].Prostate,2001,47(3):205-211.
  • 8Ferrante E,Pellegrini C,Bondioni S,et al.Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2[J].Endocr Relat Cancer,2006,13(3):955-962.
  • 9Pages P,Benali N,Saint-Laurent N,et al.sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1).Evidence for the role of SHP-1[J].J Biol Chem,1999,274(21):15186-15193.
  • 10Ferrante E,Pellegrini C,Bondioni S,et al.Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2[J].Endocr Relat Cancer,2006 ,13(3):955-962.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部